Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Globe LifeGL +0.05%83 3-Year EBITDA Growth Rate is 16.60% as of Mar. 2026, which is 43% above its 10-year median of 11.60. GuruFocus rates GL with a GF Score™ of 83/100 and a GF Value™ of $149.04 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 289 Insurance companies, Globe Life ranks worse than 51.56% on this metric.
During the past 12 months, Globe Life's average EBITDA Per Share Growth Rate was 16.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 16.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 13.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 11.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Globe Life was 103.60% per year. The lowest was -47.40% per year. And the median was 11.60% per year.
Globe Life (NYSE:GL) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Globe Life 3-Year EBITDA Growth Rate Related Terms
GL vs UNM, PRI, JXN: 3-Year EBITDA Growth Rate Comparison
For the Insurance - Life subindustry, Globe Life's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globe Life 3-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Globe Life's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Globe Life's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 16.60% mean?
Globe Life (GL) has a 3-Year EBITDA Growth Rate of 16.60% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Globe Life and its competitors. This is 43% above median its historical median of 11.60. According to the industry distribution chart, Globe Life ranks #149 out of 289 companies in the Insurance industry, placing it in the top 51.6%.
Is Globe Life's 3-Year EBITDA Growth Rate too high?
Globe Life's current 3-Year EBITDA Growth Rate of 16.60% is 43% above median its 10-year median of 11.60. The Insurance industry median 3-Year EBITDA Growth Rate is 17.50. Globe Life's value of 16.60% is 5.1% below this industry median. Based on the distribution chart, Globe Life ranks #149 out of 289 companies in the Insurance industry, which is below the industry midpoint. Overall, Globe Life has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Globe Life's 3-Year EBITDA Growth Rate compare to UNM and PRI?
According to the Insurance industry distribution chart, Globe Life ranks #149 out of 289 companies for 3-Year EBITDA Growth Rate. This places Globe Life in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 17.50. Globe Life's value of 16.60% is 5.1% below this benchmark. While the company's 10-year median is 11.60 vs. the industry median of 17.50, Globe Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Insurance company?
The median 3-Year EBITDA Growth Rate among Insurance companies is 17.50, based on 289 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globe Life's current 3-Year EBITDA Growth Rate of 16.60% is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Globe Life and its competitors. For the Insurance industry, the median 3-Year EBITDA Growth Rate is 17.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globe Life's current 3-Year EBITDA Growth Rate is 16.60%, which is 43% above median its own 10-year median of 11.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globe Life stock overvalued right now?
Based on GuruFocus' analysis, Globe Life (GL) is currently considered Modestly Overvalued. The stock's GF Value™ is $149.04, compared to a current price of $184.34 — trading 23.7% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 16.60%, which is 43% above median its 10-year median of 11.60 and 5.1% below the Insurance industry median of 17.50. Globe Life's overall GF Score™ is 83/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Globe Life (GL), the current 3-Year EBITDA Growth Rate is 16.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globe Life (GL) Overvalued in 2026?
Based on GuruFocus' analysis, Globe Life stock appears to be overvalued.
The current stock price of $184.34 is trading 23.7% above its estimated GF Value™ of $149.04.
GuruFocus considers Globe Life to be Modestly Overvalued.
Key valuation signals for GL:
3-Year EBITDA Growth Rate: 16.60% (43% above median its 10-year median of 11.60)
GF Value™: $149.04 vs. price of $184.34 (23.7% above fair value)
Industry Position: 5.1% below the Insurance median (#149 of 289)
No single metric tells the full story. See the GL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
83GF Score
Get the complete analysis for GL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GL has been successfully added to your 
